| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| JIN MEDICAL INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| 30.10. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 24.09. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.09. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.08. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 12 | SEC Filings | ||
| 04.08. | JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results | 337 | PR Newswire | CHANGZHOU, China, Aug. 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen | |
| 15.07. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.06. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 04.06. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.04. | Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement | 320 | PR Newswire | CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen | |
| 12.03. | Jin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance Initiative | 643 | PR Newswire | CHANGZHOU, China, March 11, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 0,474 | -27,04 % | Cerenome outlines $10M-$12.5M 2026 gross billings run rate exit while targeting mid-2027 REYOBIQ top line data | ||
| ATOSSA THERAPEUTICS | 1,680 | +1,20 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Nov. 10, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other... ► Artikel lesen | |
| ASENSUS SURGICAL | - | - | Karl Storz to fully integrate Asensus, discontinue Senhance, Luna robots | ||
| CO-DIAGNOSTICS | 0,197 | -0,25 % | Co-Diagnostics receives test order from Peru amid dengue rise | ||
| AMBU | 11,880 | -0,34 % | Ambu A/S: Interim Report For Q4 2025/26 And Outlook For Fy 2026/27 | 5.11.2026 07:00:06 CET | Ambu A/S |
Annual Financial Report
Strong organic revenue growth in Q4 of 13.9% and an EBIT margin of 17.2% resulted in Ambu closing the financial year within the guidance... ► Artikel lesen | |
| NOVACYT | 0,437 | 0,00 % | Novacyt's Yourgene Wins Australian Approval for DPYD Chemotherapy Toxicity Test | ||
| AETHLON MEDICAL | 5,060 | -0,98 % | Aethlon Medical GAAP EPS of -$2.60 beats by $0.10 | ||
| VIVOS THERAPEUTICS | 0,076 | 0,00 % | Vivos Therapeutics GAAP EPS of -$0.07 beats by $0.25, revenue of $6.41M beats by $0.94M | ||
| FRESENIUS MEDICAL CARE | 38,560 | -2,90 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius schließt Verkauf von 13,4 Millionen Aktien der Fresenius Medical Care zu 39,00 Euro je Aktie ab und erzielt rund 524 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius schließt Verkauf von 13,4 Millionen Aktien der Fresenius Medical Care zu 39,00... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,840 | +1,25 % | Aktie zieht an!: Siemens liefert und legt nach, die Strategie überzeugt wirft Fragen auf | © Foto: Joko - JokoSiemens meldet Rekordzahlen und hebt die Mittelfristziele an. Anleger bleiben trotzdem skeptisch, denn die neue Konzernstrategie gilt vielen noch als zu unscharf Enthaltene Werte:... ► Artikel lesen | |
| FRESENIUS | 53,43 | -0,60 % | Fresenius-Aktie und BASF-Aktie: Aktuelle Einschätzungen im Fokus | Die Aktien von Fresenius und BASF stehen im Anlegerfokus. Während Fresenius mit starken Quartalszahlen, steigender Profitabilität und neuen Kursrekorden überzeugt, setzt BASF auf eine Belebung des globalen... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,600 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Strong Results in the 2025 Performance Year of the Medicare Shared Savings Program | ||
| BILLIONTOONE | 91,50 | -0,04 % | BillionToOne weist Vorwürfe aus Leerverkäufer-Bericht zurück | ||
| BRIGHTSPRING HEALTH SERVICES | 68,35 | +0,01 % | BMO raises BrightSpring Health stock price target on LDD momentum | ||
| GENEDX | 52,19 | +0,44 % | GeneDx Taps Everett Cunningham as CEO |